HDAC family: What are the cancer relevant targets?

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161

Histone deacetylases (HDACs): characterization of the classical HDAC family

RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114

Anticancer activities of histone deacetylase inhibitors

Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919

Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain

Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559

HDAC6 is a microtubule-associated deacetylase

Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234

A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p

Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714

The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress

Kawaguchi, Y., Kovacs, J. J., McLaurin, A. C., Vance, J. M., Ito, A., & Yao, T. (2003) · Cell · doi:10.1016/s0092-8674(03)00939-5 · Cited by 1,529

Letter to the Editor: “Histone Deacetylase 7 Inhibition in a Murine Model of Gram-Negative Pneumonia-Induced Acute Lung Injury” Shock 53:344–351, 2020

Verin, A. D. (2019) · Shock · doi:10.1097/shk.0000000000001430 · Cited by 2

Integrative Structural Modeling of Intrinsically Disordered Regions in a Human HDAC2 Chromatin Remodeling ComplexPreprint

Nde, J., Kempf, C. G., Zimmermann, R. C., Cesare, J., Zhang, Y., Workman, J. L., Florens, L. A., & Washburn, M. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.08.669391 · Cited by 2

New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis

Spirin, P., Vedernikova, V., Volkava, T., Morozov, A. V., Kleymenova, A. A., Zemskaya, A. S., Shyrokova, L., Porozov, Y. B., Glumakova, K. A., Lebedev, T. D., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040416 · Cited by 1

Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study

Vajen, B., Schäffer, V., Eilers, M., Schlegelberger, B., & Skawran, B. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04896-w · Cited by 1

Preclinical Characterization of SDFZ‐8, a Highly Potent HDAC1 Inhibitor, for Cancer Immunotherapy

Zhou, Y., Du, J., Li, X., Zhao, H., Xue, J., Liu, Y., Yang, X., Yu, J., Hou, X., & Fang, H. (2025) · MedComm · doi:10.1002/mco2.70500 · Cited by 1

Synthesis of N‐aminophalimides derived from α‐amino acids: Theoretical study to find them as HDAC8 inhibitors by docking simulations and in vitro assays

Ramírez, J. E. G., & Mancilla, T. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14323 · Cited by 1

MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer

Park, J., Chen, Y.-Y., Cao, J. J., An, J., Yen, R.-W. C., Outen, J. D., Baylin, S. B., & Topper, M. J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115722 · Cited by 1

Role of Histone Modifications in Oral Squamous Cell Carcinoma

Tomar, P., Singh, D., Anand, A., Verma, S., Agarwal, N., Mathur, R., PRIYANKA, P., Pamei, S., Gupta, V. K., & Jha, A. K. (2025) · NIPES Journal of Science and Technology Research · doi:10.37933/nipes/7.2.2025.26 · Cited by 1

Discovery of Novel Benzyl indole Histone Deacetylase Inhibitors for Efficient Treatment of Colorectal Cancer

Zhao, Y., Zhang, M.-Y., Liang, Z., Liu, X., Kong, W., Hu, L., Zhou, Y.-C., Lv, K., Zhao, M., Chen, D., et al. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143787 · Cited by 1

Design, synthesis and anti-cervical cancer activity of aroylpyrrole-based derivatives as potent histone deacetylase 6 inhibitors

Wang, X., Du, L., Xue, Y., Su, Y., Yuan, X., Yang, S., Su, W., Gou, W., Chen, X., & Zong, L. (2025) · RSC Advances · doi:10.1039/d5ra06970j · Cited by 1

Quinoline/Pyrido‐Pyrimidine Derivatives as Tubulin Polymerization Inhibitors: Design, Synthesis, Computational, and Anticancer Evaluation

Arya, D., Khan, G. A., Singh, S., Upadhyay, A., Sharma, B. P., Maharjan, R., Sharma, M. L., Gupt, M. P., Dubey, S. S., Pathak, P., et al. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70172 · Cited by 1

Targeted HDAC8 inhibition with non-hydroxamate [1,2,4]triazolo[4,3-a] quinoline compounds

Bandaru, N. V. M. R., Fathima, A., Sengar, S., Schweipert, M., Chaitanya, K. S., Mohammed, M.-U.-R., Gore, S. T., Trinath, J., Sharma, V., Abbineni, C., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-38490-y · Cited by 1

PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators

Periyasamy, S., Jarrett, T., Truong, J., & Skouta, R. (2026) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2026.2636394 · Cited by 2

Multifunctional SAHA-derived 8-hydroxyquinoline metallopharmacophores: HDAC inhibition and antiproliferative activity

Chen, C., Havlínová, B., Vošahlíková, M., Tuckova, R., Stjärnhage, J., Lin, Z., Rayner, C., Bařinka, C., Söhnel, T., Jamieson, S. M. F., et al. (2026) · Inorganic Chemistry Frontiers · doi:10.1039/d6qi00422a · Cited by 1

PI3K/HDAC Dual Inhibitors as Potential Anticancer Therapeutics: An Insight Into Design Strategies and Structure Activity Relationships

Dash, S., Shehensha, S., & Dhar, A. K. (2026) · ChemistrySelect · doi:10.1002/slct.73651 · Cited by 1

Therapeutic potential of histone deacetylase inhibitors for breast cancer

Viswanathan, S., Carothers, S., & Ramaswamy, B. (2011) · Clinical Investigation · doi:10.4155/cli.11.29 · Cited by 1

A Sensitive and Flexible Assay for Determining Histone Deacetylase 1 (HDAC1) Activity

Wu, M.-Y., & Wu, R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_1 · Cited by 1

Chromatin Signaling in Aging and Cellular Senescence

Couteau, F., & Mallette, F. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00016-2 · Cited by 1

Assessment of HDACi-Induced Protein Cleavage by Caspases

Treude, F., Gladbach, T., Plaster, J., & Hartkamp, J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6527-4_2 · Cited by 1

Assessing HDAC Function in the Regulation of Signal Transducer and Activator of Transcription 5 (STAT5) Activity Using Chromatin Immunoprecipitation (ChIP)

Pinz, S., & Rascle, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6527-4_19 · Cited by 1

Rapid Detection of p53 Acetylation Status in Response to Cellular Stress Signaling

Farkaš, M., & McMahon, S. B. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9434-2_15 · Cited by 1

Epigenetic regulation and microRNA expression

Jurj, A. M., Zănoagă, O., Braicu, C., & Berindan‐Neagoe, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00003-0 · Cited by 1

Synthetic Study on Bicyclic Depsipeptides Containing an Intramolecular Disulfide Bond

Narita, K. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.22-00091 · Cited by 1

A Reactivity‐Tunable Self‐Immolative Design Enables Histone Deacetylase‐Targeted Imaging and Prodrug Activation

Liu, F., Ding, X., Xu, X., Wang, F., Chu, X., & Jiang, J. (2022) · Angewandte Chemie · doi:10.1002/ange.202203243 · Cited by 1

A COMPARATIVE ANALYSIS TO DETERMINE THE OPTIMUM HISTONE DEACETYLASE INHIBITORS AND ADMINISTRATION ROUTE FOR IMPROVING SURVIVAL AND ORGAN INJURY IN RATS AFTER HEMORRHAGIC SHOCK

Niu, K., Yang, L., Song, W., Liu, Z., Yuan, J., Zhang, H., Zhang, W., Wang, J., & Tao, K. (2023) · Shock · doi:10.1097/shk.0000000000002136 · Cited by 1

Epigenetic therapies: histone deacetylases

Blanquart, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91367-6.00022-2 · Cited by 1

Histone deacetylase inhibitory and antioxidant activities of some ethanolic plant extracts: A novel therapeutic approach for cancer

Dağsuyu, E., & Yanardağ, R. (2023) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1316664 · Cited by 1

A Novel Chemotherapy Combination to Enhance Proteotoxic Cell Death in Hepatocellular Carcinoma Experimental Models Without Killing Non-Cancer Cells

Perez‐Stable, C., Pozas, A. D. L., Reiner, T., Gomez, J., Nagarajan, M. K., Foster, R. T., Ure, D., & Wangpaichitr, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146699 · Cited by 1

Cardiac Plasticity in Health and Disease

Gondalia, R., Rothermel, B. A., Lavandero, S., Gillette, T. G., & Hill, J. A. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_7 · Cited by 1

Controversies Surrounding the Potential Use of Histone Deacetylase Inhibitors for the Treatment of Asthma

Royce, S. G., Ververis, K., & Karagiannis, T. C. (2012) · ISRN Pulmonology · doi:10.5402/2012/452307 · Cited by 1

Pubertal supplementation of lipotropes in female rats reduces mammary cancer risk by suppressing histone deacetylase 1

Cho, K., Choi, W., Crane, C. L., & Park, C. S. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0626-3 · Cited by 1

Epigenetik des Urothelkarzinoms

Niegisch, G., Hoffmann, M. J., Koutsogiannouli, E. A., & Schulz, W. A. (2015) · Der Urologe · doi:10.1007/s00120-014-3756-1 · Cited by 1

Hydroxamic Acids as Potent Antioxidants and Their Methods of Evaluation

Mehndiratta, S., Nepali, K., & Satapathy, M. K. (2017) · Springer eBooks · doi:10.1007/978-981-10-4711-4_5 · Cited by 1

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [18F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain

Clauß, O., Schäker‐Hübner, L., Wenzel, B., Toussaint, M., Deuther‐Conrad, W., Gündel, D., Teodoro, R., Dukić-Stefanović, S., Ludwig, F., Kopka, K., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15030324 · Cited by 1

Epigenetic Biomarkers in Toxicology

Chintalapati, A. J., & Barile, F. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814655-2.00045-1 · Cited by 1

Polypharmacology in Clinical Applications—Anticancer Polypharmacology

Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_3 · Cited by 1

Modeling anticancer pharmacophore based on inhibition of HDAC7

Laboratoire de Thermodynamique et de Physico-Chimie du Milieu, U. D. F. E. D. R. S. F. E. A., Affi, S. T., Doh, S., Coulibaly, S., Konaté, B., & Ziao, N. (2021) · SDRP Journal of Computational Chemistry & Molecular Modelling · doi:10.25177/jccmm.5.3.ra.10776 · Cited by 1

Novel (E)‐3‐(3‐Oxo‐4‐substituted‐3,4‐dihydro‐2H‐benzo[b][1,4]oxazin‐6‐yl)‐N‐hydroxypropenamides as Histone Deacetylase Inhibitors: Design, Synthesis and Bioevaluation

Sang, D. M., Na, I. H., Anh, D. T., Dung, D. T. M., Hang, N. T. T., Phuong‐Anh, N. T., Pham‐The, H., Oanh, D. T. K., Tùng, T. T., Lee, S. J., et al. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202201030 · Cited by 1

Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3

Feng, D. (2013) · ScholarlyCommons (University of Pennsylvania) · Cited by 1

THE HISTONE DEACETYLASE INHIBITOR, MS-275, SENSITIZES METASTATIC OSTEOSARCOMA TO FASL-INDUCED CELL DEATH: A ROLE FOR C-FLIP

Rao‐Bindal, K. (2012) · Digital Commons-TMC (Texas Medical Center) · Cited by 1

Histone Deacetylase 1 inhibit primary hippocampal neuron dendritic growth and branching by regulation of neuronal MHC class Ⅰ moleculesPreprint

Shen, Y., Pei, W., Sun, C., Hu, Y., Li, P., Shen, Y., Zhang, Y., Miao, F., & Zhang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1863747/v1 · Cited by 1

Exploration de l’impact de l’exposition chronique et faibles doses de facteurs environnementaux sur les cellules pré-cancéreuses mammaires MCF10AT1

Helou, M. E. (2017) · theses.fr (ABES) · doi:10.70675/0c7d676dz64a3z4641zb8cbzd99a75ef2126 · Cited by 1

Mechanisms Associated with the Chemotherapeutic Effects of Zyflamend, a Multi-Herbal Extract, on Advanced Prostate Cancer

Huang, E. (2010)

The Discovery of Anticancer Drugs Targeting Epigenetic Enzymes

Ganesan, A. (2012) · Wiley eBooks · doi:10.1002/9783527651085.ch5

Epigenetic Control of Tumor Suppressor Genes in Lung Cancer

Qiu, X., Perez-Soler, R., & Zou, Y. (2012) · InTech eBooks · doi:10.5772/26592

3D MODELING AND CHARACTERIZATION OF HDAC9

Samant, L. R., Sangar, V. C., Khanzode, M., & Chowdhary, A. S. (2014) · International Journal of Pharmacy and Pharmaceutical Sciences

Anti‐Ageing Strategy of the Lung for Chronic Inflammatory Respiratory Disease – Targeting Protein Deacetylases

Ito, K., & Mercado, N. (2012) · Wiley eBooks · doi:10.1002/9781119967309.ch5

A Synthetic Biology Approach to Engineering New Anticancer Agents

Wesener, S. R. (2013) · UWM Digital Commons (University of Wisconsin–Milwaukee)

Regulació de l'heterocromatina constitutiva en condicions normals i d'estrès: Paper de SirT1 i d'HP1

Raurell‐Vila, H. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Clinical takeoff for new epigenetic targets

Lou, K.-J. (2013) · Science-Business eXchange · doi:10.1038/scibx.2013.1118

The role of epigenetics in breast cancer progression

Yıldırım, A. (2013) · Utrecht University Repository (Utrecht University)

Development of Fluorogenic Probes for the Detection of Histone Deacetylase Activity

Hori, Y., Baba, R., & Kikuchi, K. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00202-3

[Diagnosis and treatment of nephroptosis in flying personnel].

Гарилевич, Б. А., & Avdeĭchuk, I. I. (1997) · PubMed

An Overview of Epigenetic Mechanisms in Health and Disease

Westerland, C., & Karagiannis, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0706-9_3

p90 and UHRF1, Two Novel Regulators of the p53 Signaling Pathway

Dai, C. (2014) · doi:10.7916/d8sq8xcj

Isoform-Selective HDAC Inhibition for the Treatment of Lupus Nephritis

Regna, N. L. (2014) · VTechWorks (Virginia Tech)

GENOTOXIN-INDUCED ACETYLATION OF THE WERNER SYNDROME PROTEIN (WRN) AND EFFECT ON ITS DNA METABOLIC FUNCTION

Lozada, E., & Santiago, L. (2011) · UKnowledge (University of Kentucky)

Molecular and functional intra-tumoral heterogeneity in adult Acute Myelogenous Leukemia

Sermet, K. (2014)

Elucidation of the Histone Deacetylase 6 Pharmacophore

Kalin, J. H. (2012) · Figshare

Rôle de l’acétylation/déacétylation des histones dans la régulation de l’expression des gènes de la COX-2, iNOS et mPGES-1 dans les tissus articulaires

Chabane, N. (2012) · doi:10.71781/29709

Effect of DNA methylation and histone modification during the de-velopment of cloned animals

Guo, L., Li, H., & Han, Z. (2010) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2010.00762

Researchattenuates TRAIL-induced apoptosis of pancreatic cancer cells

Schüler, S., Fritsche, P., Diersch, S., Arlt, A., Schmid, R. M., Saur, D., & Schneider, G. (2010)

The Role of Histone Deacetylases in Glucose Metabolism: a Mini- Review

Liu, F. (2015) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.113

Evaluation of Photoreactive and Phenothiazine-based HDAC Inhibitors

Madriaga, A. (2014) · Figshare

Epigenetics of Dental Stem Cells

Duncan, H. F., & Cooper, P. R. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-33299-4_4

Regulation of Secretory Phospholipase A2 by Thyroid Hormone

Sharma, P. (2013) · doi:10.21007/etd.cghs.2013.0286

Role of lipotropic (methyl) nutrients on mammary development and carcinogenesis in female rat offspring

Cho, K. B. (2015) · NDSU Repository (North Dakota State University)

Chapter 11 Zyfl amend and Prostate Cancer Therapy

Whelan, J. N., Zhao, Y., Huang, E., MacDonald, A., & Donohoe, D. R. (2016) · Traditional herbal medicines for modern times · doi:10.1201/9781315370156-12

NUCLEOCYTOSKELETAL CONNECTIONS IN MECHANOTRANSDUCTION

Chambliss, A. B. (2014)

Role of endogenous retrovirus promoter activity in tumor suppression

Krönung, S. K. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5097

Adaptation of colon cancer cells to histone deacetylase inhibitors generates cell lines with a non-malignant phenotype

Vengsarkar, D. (2016) · doi:10.7282/t3qn68z9

Investigating the role of epigenetics in scar maintenance

Stevenson, A. W. (2016) · UWA Profiles and Research Repository (UWA)

Die Funktionsanalyse und Pharmakomodulation des Amyloid-Vorläufer-Proteins (APP) in vitro und in vivo - Eine neue Zielstruktur zur Behandlung maligner Tumore

Venkataramani, V. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1184

Las HDAC en la regulación de la expresión génica y el cáncer

Fernández, A. B. (2014) · MoleQla: revista de Ciencias de la Universidad Pablo de Olavide

Functional Characterization and Structure Prediction of HDAC-10: A Bioinformatics Approach

Sabeena, M., Jamil, K., & Nehru, J. (2014)

Einfluss von HDAC-Inhibitoren auf die Expression IFNγ-regulierter Gene und die Parasitenentwicklung in Toxoplasma gondii-infizierten Makrophagen

Sumpf, K. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6571

Identification and characterisation of novel cancer testis antigens in human cancer cells

Alsiwiehri, N. O. (2017) · Bangor University Research Portal (Bangor University)

Epigenetics in Melanoma

Askarian-Amiri, M., Rodger, E. J., Chatterjee, A., Finlay, G. J., & Baguley, B. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-78310-9_7

HAT-HDAC System in Asthma

Sun, X., Chen, Z. H., & Wang, X. (2018) · Translational bioinformatics · doi:10.1007/978-981-10-8764-6_12

The mutations identified in human HDAC-10 gene and their prognosis in cancer cases

Sabeena, M., Jamil, K., & Swamy, A. V. N. (2018) · INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE AND HEALTH CARE · doi:10.26808/rs.ph.i8v3.04

HDAC2, HDAC4, HDAC5, HDAC7, HDAC8, HDAC9 Gen İfade Seviyelerinin Çocukluk Çağı Akut Lösemilerinde Prognoz İle İlişkisi

Bali, D., Kürekçi, A. E., & Akar, M. N. (2018) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.373907

Leki wpływające na mechanizmy epigenetyczne w ostrej białaczce szpikowej

Wiśniewski, K., & Góra‐Tybor, J. (2018) · Hematologia · doi:10.5603/hem.2018.0014

Target Identification of HDAC8 Isoform for the Treatment of Cancer

Umamaheswari, A., Puratchikody, A., & Balasubramaniyan, S. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-7326-5.ch007

Classical And Ab Initio Qm/mm Simulations Of Bacterial Enzymes

Dewage, S. W. (2015)

Expression of HDAC8 indicates poor prognosis of esophageal squamous cell carcinoma and progression to advanced stage

Yufeng, C., Nesa, E. U., Chen, X., Wang, C., Chen, X., Wang, Y., Qu, Y., Mi, S., Guan, S., Zahur, T., et al. (2019) · International Journal of Cancer and Oncology · doi:10.15436/2377-0902.19.2465

Epigenetic and Transcriptional Response to HDAC Inhibition in Triple Negative Breast Cancer Cells

Walheim, D. M. (2016)

The efficacy of HDAC inhibitors in neoplasm treatment

Psiuk, D., Rocka, A. A., Żak, K., Tomczyk, Z., & Filip, A. A. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.08.028

Target Proteins Involved in Aging Mechanism as an Aging Molecular Marker

Kim, M. (2016) · Journal of Life Science · doi:10.5352/jls.2016.26.8.983

MAGNETIC DEVICES IN GLASS APPARATUS. PART II

Gamisch, G., & Ruettiger, W. (1958) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)

Epigenetic Signatures of Breast Cancer Genes

Anant, S., Dhar, A., & Ramalingam, S. (2013) · Springer eBooks · doi:10.1007/978-94-007-6612-9_10

Impacto de los inhibidores de Deacetilasas de Histonas (iHDAC) sobre la funcionalidad de células NK

Rossi, L. E. (2012) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)

Faculty Opinions recommendation of Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles.

Sweatt, J. D., & Day, J. J. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718018322.793478215

Epigenomic Imaging of Neuropsychiatric Diseases

Bahari‐Javan, S. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4280

Full PDF of Hematology Reviews 2009, volume 1, issue 1.

Editors, T. L. O. (2011) · Hematology Reports · doi:10.4081/1716

"HDAC Inhibitors: Novel Therapies in Combination with Immune Checkpoint Inhibitors for Treatment of Advanced and Unresectable Melanoma - A Mini Review"

Ning, J. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.43.006887

synthesis-and-evaluation-of-novel-hydroxamic-acid-based-histone-deacetylase-inhibitors-as-anti-cancer-agents/#

(2017) · Cancer Studies and Therapeutics · doi:10.31038/cst.2017223

Is the effect of Decitabine limited to hypomethylation and DNMTs?Preprint

Dalvand, S., Namdari, A., Alemi, A., Meshkibaf, M. H., Setayesh, S., Karamallah, M. H., & Farrokhifar, M. (2019) · Research Square · doi:10.21203/rs.2.13184/v1

Effect of 2,6-diketopiperazines derived from α-amino acids over MDA-MB-231 breast cancer cell linePreprint

González, F. P. G., Jiménez, E. M., & Mancilla, T. (2022) · Research Square · doi:10.21203/rs.3.rs-2354174/v1

Investigating the impact of key tumor markers to predict and reduction of lymphoma cancer diagnosis duration with a data mining approachPreprint

Ghorbian, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2664627/v1

Data from SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer

Novotny‐Diermayr, V., Sangthongpitag, K., Hu, C. Y., Wu, X., Sausgruber, N., Yeo, P., Greicius, G., Pettersson, S., Liang, A. L., Loh, Y. K., et al. (2023) · doi:10.1158/1535-7163.c.6531900.v1

Progress in the Research of Selective Histone Deacetylase Inhibitors

Lü, S. (2010) · The Chinese Journal of Modern Applied Pharmacy

In Silico Approaches Towards Safe Targeting of Class I Histone Deacetylases

Ganai, S. A. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6436-5_459-1 · Cited by 11

5 Histone Deacetylase Inhibitors: A Novel Class of Anti-Cancer Agents on its Way to the Market

Körner, M., & Tibes, U. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00005-7 · Cited by 13

Protected from the inside: Endogenous histone deacetylase inhibitors and the road to cancer

Marcotullio, L. D., Canettieri, G., Infante, P., Greco, A., & Gulino, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.01.002 · Cited by 51

Targeting class I histone deacetylases in cancer therapy

Delcuve, G. P., Khan, D. H., & Davie, J. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.729042 · Cited by 66